Improving DxMultiomics, Powered by Your Choices

We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.

BioAro launches AI-Driven PanOmiQ with Ultrafast Whole Genome Sequencing Analysis Technology
_↗ bioaro.com
News Image

BioAro, a global leader in precision health and genomics, is poised to unveil its revolutionary AI-powered PanOmiQ platform at the Precision Medicine World Conference (PMWC) in Silicon Valley. This groundbreaking Whole Genome Sequencing (WGS) solution dramatically cuts analysis time to under two hours and generates Variant Call Format (VCF) files in under five minutes, a historic achievement that redefines AI-driven genomic analysis and precision medicine. This unprecedented efficiency, combined with proven accuracy—highlighted by a 100% match in College of American Pathologists (CAP) proficiency testing—makes advanced genomics more accessible and affordable than ever before, democratizing a critical tool for healthcare globally. Beyond WGS, PanOmiQ also offers Whole Exome Sequencing and real-time microbiome analysis, integrating diverse health dimensions to empower proactive, preventative care and drive groundbreaking discoveries. This transformative platform enables clinicians to act on real-time genetic insights, accelerating precision diagnostics and optimizing treatment plans, ultimately improving patient outcomes and extending human longevity across a wide range of diseases, from cancer and rare genetic conditions to chronic disease management and personalized nutrition.

Log In
Sign Up